Evidence map›Paper›PMID 28580135›Full record

ArticleF1000Research2017

SNP-SNP interactions as risk factors for aggressive prostate cancer.

Venkatesh Vaidyanathan, Vijay Naidu, Nishi Karunasinghe, Anower Jabed, Radha Pallati, Gareth Marlow, Lynnette R Ferguson

Open access · goldAbstract read
In one paragraph

Article in F1000Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Venkatesh VaidyanathanDiscipline of Nutrition and Dietetics, FM & HS, University of Auckland, Auckland, New Zealand.ORCID 0000-0002-9299-617X
Vijay NaiduSchool of Engineering,Computer and Mathematical Sciences, Auckland University of Technology, Auckland, New Zealand.
Nishi KarunasingheAuckland Cancer Society Research Centre, Auckland, New Zealand.
Anower JabedDepartment of Molecular Medicine and Pathology, FM & HS, University of Auckland, Auckland, New Zealand.
Radha PallatiDiscipline of Nutrition and Dietetics, FM & HS, University of Auckland, Auckland, New Zealand.
Gareth MarlowExperimental Cancer Medicine Centre, Cardiff University, Cardiff, UK.
Lynnette R FergusonDiscipline of Nutrition and Dietetics, FM & HS, University of Auckland, Auckland, New Zealand.
University of Auckland · NZAuckland University of Technology · NZCancer Society of New Zealand · NZCardiff University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (PCa) is one of the most significant male health concerns worldwide. Single nucleotide polymorphisms (SNPs) are becoming increasingly strong candidate biomarkers for identifying susceptibility to PCa. We identified a number of SNPs reported in genome-wide association analyses (GWAS) as risk factors for aggressive PCa in various European populations, and then defined SNP-SNP interactions, using PLINK software, with nucleic acid samples from a New Zealand cohort. We used this approach to find a gene x environment marker for aggressive PCa, as although statistically gene x environment interactions can be adjusted for, it is highly impossible in practicality, and thus must be incorporated in the search for a reliable biomarker for PCa. We found two intronic SNPs statistically significantly interacting with each other as a risk for aggressive prostate cancer on being compared to healthy controls in a New Zealand population.

Indexed as

prostate cancerSEQUENOM MassArray technologySNP genotypingSNP-SNP interaction

Identifiers

PMID28580135
PMCPMC5437948
OpenAlexW2610727175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.